Buy & Sell Sanofi SA (SNY) – Sanofi SA Price Today
Aura AI Summary
Key Stats
- $108.34BMarket Cap
- HealthSector
- -12.06%3M Drawdown
- $125.15BEnterprise Value
- 5.37%Dividend Yield
- 90 daysTypical Hold Time
Sanofi SA (SNY) is currently valued at a market capitalization of $108.34B, with an enterprise value of $125.15B. Over the past 52 weeks, Sanofi SA has traded between a low of $42.37 and a high of $52.34, highlighting its annual price range. Over the past three months, Sanofi SA has recorded a drawdown of -12.06%, reflecting recent price volatility. Sanofi SA offers a dividend yield of 5.37%, with the most recent dividend of $2.42 paid on 04 May 26. On average, investors hold Sanofi SA for approximately 90 days, indicating typical investor behavior on the platform.
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Most Recent News
OpenAI plans major upgrade to boost ChatGPT amid IPO and competition with Anthropic.
OpenAI is preparing its biggest upgrade yet, transforming ChatGPT into a superapp with multiple tools like coding and AI agents to better compete with Anthropic. This move aims to attract more corporate clients and increase revenue as OpenAI readies ...

Investors may claim losses after ADMA Biologics shares fell 16.6% amid fraud allegations.
Rosen Law Firm is investigating securities claims against ADMA Biologics following allegations that the company misled investors by inflating revenue through channel stuffing. The stock dropped 16.6% on March 24, 2026, after a short seller report by ...

Anthropic co-founder warns AI industry lacks a 'brake pedal' amid rapid growth and IPO plans.
Anthropic, an AI company backed by Amazon and Google, is preparing for a major IPO potentially valuing it near $1 trillion. Co-founder Jack Clark cautions that the AI industry currently has no mechanism to slow development, likening it to having a ga...
